share_log

Revance Therapeutics | 8-K: Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

SEC ·  Nov 9, 2023 05:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more